Communications & Resources

Episode 1: What is the Heart Failure Collaboratory?

Episode 2: Contemporary Challenges in HF Clinical Trial Design

Episode 3: Statistical Considerations in Heart Failure Research

Episode 4: The Intersection of Heart Failure and the Kidney

Episode 5: Diversity in Heart Failure Clinical Trials

2022 Awardees Recognized at HFSA Annual Scientific Meeting

Ellis Unger Honored with HFC Lifetime Achievement Award

HFC call to action featured in TCTMD

HFC Abstracts Presented at ACC.22

HFC guidance on recruiting diverse populations highlighted in ACC newsletter

HFC/HFSA Research Award Nominations

HFC Lean CRF: Hemodynamics

HFC Lean CRF: Short-Term Mechanical Circulatory Support (MCS) Module

HFC Lean CRF: Echocardiography Module

HFC Lean CRF: Magnetic Resonance Imaging Module

HFC Lean CRF: Expanded Laboratory Details

HFC Lean CRF: Durable Mechanical Circulatory Support (MCS) Module

HFC Lean CRF: Electrocardiogram Details Module

HFC Lean Case Report Form

HFC COVID-19 Data Capture Form

Download the COVID-Like Illness CRF Template

Read the related JACC publication “Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel”.

Return to HFC Communications & Resources

HFC Letter - Impact of COVID-19

Dear Friends and Colleagues,

The mission of the HFC has focused largely on clinical trials, and the impact of COVID-19 on clinical research will be significant. The FDA has issued the following guidance with suggestions and recommendations. We have offered to collect any questions not addressed in the guidance and pass them along on behalf of HFC members. We hope this will be helpful in answering the many questions we are all facing.

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-pandemic

Kind regards,

Mona Fiuzat, Chris O’Connor, JoAnn Lindenfeld, Bill Abraham, Mitch Psotka, Bram Zuckerman, Norman Stockbridge
Heart Failure Collaboratory Co-Chairs and Members

FDA guidance on statistical considerations for clinical trials during the pandemic

NIH Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19